Oncostatin m, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130

Journal of Experimental Medicine

Volumn 179, Issue 4, 1994, Pages 1343-1347

  Nishimoto, Norihiro ^a   Ogata, Atsushi ^a   Shima, Yoshihito ^a   Tani, Yoshihiko ^a   Ogawa, Hiroyasu ^a   Nakagawa, Masashi ^a   Sugiyama, Haruo ^a   Yoshizaki, Kazuyuki ^a   Kishimoto, Tadamitsu ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MONOCLONAL ANTIBODY; ONCOSTATIN M;

ADULT; ARTICLE; CANCER INHIBITION; CASE REPORT; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; MALE; PLASMACYTOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; BONE NEOPLASMS; CASE REPORT; CELL DIVISION; GROWTH INHIBITORS; HUMAN; INTERLEUKIN-11; INTERLEUKIN-6; LYMPHOKINES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGE; MULTIPLE MYELOMA; PEPTIDES; PLASMACYTOMA; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0028344845     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.179.4.1343     Document Type: Article

References (30)

1. Kishimoto, T. 1989. The biology of interleukin-6. Blood. 74:1.
2. Nordan, R., and M. Potter. 1986. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science (Wash. DC). 233:566.
3. 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med. 165:914.
4. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, et al. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature (Lond.) 332:83.
5. Klein, B., X.-G. Zhang, M. Jourdan, J. Content, F. Hous-siau, L. Aarden, M. Piechaczyk, and R. Bataille. 1989. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood. 73:517.
6. Klein, B., J. Wijdenes, X.-G. Zhang, M. Jourdan, J.-M. Boiron, J. Brochier, J. Liautard, M. Merlin, C. Clement, B. Morel-Fournier, et al. 1991. Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood. 78:1198.
7. Paul, S.R., F. Bennett, J.A. Calvetti, K. Kelleher, C.R. Wood, R.M. O’Hara, Jr., A.C. Leary, B. Sibley, S.C. Clark, D.A. Williams, and Y.-C. Yang. 1990. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl. Acad. Sci. USA. 87:7512.
8. Yang, Y.-C., and T. Yin. 1992. Interleukin-11 and its receptor. Biofactors. 4:15.
9. Rose, T.M., and A.G. Bruce. 1991. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor and interleukin 6. Proc. Natl. Acad. Sci. USA. 88:8641.
10. Hilton, D.J., and N.M. Gough. 1991. Leukemia inhibitory factor: a biological perspective. J. Cell. Biochem. 46:21.
11. Stockli, K.A., F. Lottspeich, M. Sendtner, P. Masaiakowski, P. Carroll, R. Gotz, D. Lindholm, and H. Thoenen. 1989. Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor. Nature (Lond.). 342:920.
12. Gearing, D.P., M.R. Comeau, D.J. Friend, S.D. Gimpel, C.J. Thut, J. Mcgourty, K.K. Brasher, J.A. King, S. Gillis, B. Mosley, et al. 1992. The IL-6 signal transducer, gpl30: an oncostatin M receptor and affinity converter for the LIF receptor. Science (Wash. DC). 255:1434.
13. Kishimoto, T., S. Akira, and T. Taga. 1992. Interleukin-6 and its receptor: a paradigm for cytokines. Science (Wash. DC). 258:593.
14. Taga, T., M. Narazaki, K. Yasukawa, T. Saito, D. Miki, M. Hamaguchi, S. Davis, M. Shoyab, G.D. Yancopoulos, and T. Kishimoto. 1992. Functional inhibition of hematopoietic- and neutrotropic-cytokines (LIF, OM, and CNTF) by blocking IL-6 signal transducer, gpl30. Proc. Natl. Acad. Sci. USA. 89:10998.
15. Liu, J., B. Modrell, A. AruflFo, J.S Marken, T. Taga, K. Yasukawa, M. Murakami, T. Kishimoto, and M. Shoyab. 1992. Interleukin-6 signal transducer gpl30 mediates oncostatin M signaling. J. Biol. Chent. 267:16763.
16. Iwato, K., M. Kawano, H. Asaoku, O. Tanabe, H. Tanaka, and A. Ruramoto. 1988. Separation of human myeloma cells from bone marrow aspirates in multiple myeloma and their proliferation and M-protein secretion in vitro. Blood. 72:562.
17. Hirata, Y., T. Taga, M. Hibi, N. Nakano, T. Hirano, and T. Kishimoto. 1989. Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies J Immunol 143:2900.
18. Hibi, M., M. Murakami, M. Saito, T. Hirano, T. Taga, and T. Kishimoto. 1990. Molecular cloning and expression of an IL-6 signal transducer, gpl30. Cell 63:1149.
19. Sato, K., M. Tsuchiya, J. Saldanha, Y. Koishihara, Y. Ohsugi, T. Kishimoto, and M.M. Bendig. 1993. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. Cancer Res. 53:851.
20. Saito, T., T. Taga, D. Miki, K. Futatsugi, H. Yawata, T. Kishimoto, and K. Yasukawa. 1993. Preparation of monoclonal antibodies against the IL-6 signal transducer, gpl30, that can inhibit IL-6-mediated functions. J. Immunol Methods. 163:217.
21. Ogata, A., H. Tagoh, T. Lee, T. Kuritani, Y. Takahara, T. Shimamura, H. Ikegami, M. Kurimoto, K. Yoshizaki, and T. Kishimoto. 1992. New highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmuno-assay (DELFIA). J. Immunol. Methods. 148:15.
22. Greipp, P.R., N.M. Raymond, R.A. Kyle, and W.M. O’Fallon. 1985. Multiple myeloma: significance of plasmablastic subtype in morphological classification. Blood. 65:305.
23. Paul, S.R., B.A. Barut, F. Bennett, M.A. Cochran, and K.C. Anderson. 1992. Lack of a role of interleukin 11 in the growth of multiple myeloma. Leuk. Res. 16:247.
24. Kawano, M., N. Huang, H. Harada, Y. Harada, A. Sakai, H. Tanaka, K. Iwato, and A. Kuramoto. 1993. Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood. 82:564.
25. Kawano, M., N. Huang, H. Tanaka, H. Ishikawa, A. Sakai, O. Tanabe, M. Nobuyoshi, and A. Kuramoto. 1991. Homo-typic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules. Br. J. of Haematol. 79:583.
26. Uchiyama, H., B.A. Barut, D. Chauhan, S.A. Cannistra, and K.C. Anderson. 1992. Characterization of adhesion molecules on human myeloma cell lines. Blood. 80:2306.
27. Nair, B.C., A.L. DeVico, S. Nakamura, T.D. Copeland, Y. Chen, A. Patel, T. O’Neil, S. Oroszlan, R.C. Gallo, and M.G. Sarngadhamn. 1992. Identification of a major growth factor for AIDS-Kaposi’s sarcoma cells as oncostatin M. Science (Wash. DC). 255:1430.
28. Lotz, M., T. Moats, and P.M. Villiger. 1992. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to pathogenesis of arthritis. J. Clin. Invest. 90:888.
29. Kubagawa, H., L.B. Vogler, J.D. Capra, M.E. Conrad, A.R. Lowton, and M.D. Cooper. 1979. Studies on the clonal origin of multiple myeloma. Use of individually specific (idiotype) antibodies to trace the oncogenic event to its earliest point of expression in B-cell differentiation. J. Exp. Med. 150:792.
30. Caligaris-Cappio, F., L. Bergui, L. Tesio, G. Pizzolo, F. Malavasi, M. Chilosi, D. Campana, B. Van Camp, and G. Jonossy. 1985. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma. J. Clin. Invest. 76:1243.